相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide
Gokhan Baris Ozdener et al.
MOLECULAR ONCOLOGY (2016)
Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice
C. Wei et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2016)
Proteases decode the extracellular matrix cryptome
Sylvie Ricard-Blum et al.
BIOCHIMIE (2016)
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications
Amit Walia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops
Xinke Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
The roles of nucleolin subcellular localization in cancer
Caroline Madeleine Berger et al.
BIOCHIMIE (2015)
Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment
Ilkka Alahuhta et al.
EXPERIMENTAL CELL RESEARCH (2015)
Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin
Laura M. McDonell et al.
HUMAN MOLECULAR GENETICS (2015)
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model
Tetsuya Nishimoto et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer
Shun Lu et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
MMP generated matrikines
J. Michael Wells et al.
MATRIX BIOLOGY (2015)
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Renato V. Iozzo et al.
MATRIX BIOLOGY (2015)
Endostatin Has ATPase Activity, Which Mediates Its Antiangiogenic and Antitumor Activities
Shan Wang et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Conditionally replicating oncolytic adenoviral vector expressing arresten and tumor necrosis factor-related apoptosis-inducing ligand experimentally suppresses lung carcinoma progression
Shudong Li et al.
MOLECULAR MEDICINE REPORTS (2015)
Versican silencing improves the antitumor efficacy of endostatin by alleviating. its induced inflammatory and immunosuppressive changes in the tumor microenvironment
Zi Wang et al.
ONCOLOGY REPORTS (2015)
Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells
Dongmei Bao et al.
PROTEIN AND PEPTIDE LETTERS (2015)
Selective Binding of Endostatin Peptide 4 to Recombinant VEGF Receptor 3 In Vitro
Kyu-Yeon Han et al.
PROTEIN AND PEPTIDE LETTERS (2015)
Emerging properties of adhesion complexes: what are they and what do they do?
Jonathan D. Humphries et al.
TRENDS IN CELL BIOLOGY (2015)
Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents
Xin He et al.
ONCOTARGETS AND THERAPY (2015)
Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma
Sang-Hyun Lee et al.
ONCOTARGET (2015)
Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
Hongcheng Zhu et al.
SCIENTIFIC REPORTS (2015)
Heparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell Migration
Mariana A. Soares et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Cancer microenvronment and inflammation: role of hyaluronan
Dragana Nikitovic et al.
FRONTIERS IN IMMUNOLOGY (2015)
The role of CD44 in disease pathophysiology and targeted treatment
Andre R. Jordan et al.
FRONTIERS IN IMMUNOLOGY (2015)
Hyaluronan - a functional and structural sweet spot in the tissue microenvironment
James Monslow et al.
FRONTIERS IN IMMUNOLOGY (2015)
Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer
Suniti Misra et al.
FRONTIERS IN IMMUNOLOGY (2015)
The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability
Cornelia S. Hahn et al.
SCIENCE ADVANCES (2015)
Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour
John R. Couchman et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2015)
Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1
Lifang Guo et al.
MOLECULAR CARCINOGENESIS (2015)
T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy
Fuhai Wang et al.
ONCOLOGY REPORTS (2015)
Inhibitory effect of polysulfated heparin endostatin on alkali burn induced corneal neovascularization in rabbits
Zhao-Na Li et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2015)
Endostatin Level in Cerebrospinal Fluid of Patients with Alzheimer's Disease
Romain Salza et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin
Quliang Gu et al.
ANTI-CANCER DRUGS (2014)
Expression of liver-targeting peptide modified recombinant human endostatin and preliminary study of its biological activities
Y. Ma et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Extended interaction network of procollagen C-proteinase enhancer-1 in the extracellular matrix
Romain Salza et al.
BIOCHEMICAL JOURNAL (2014)
Syndecans in angiogenesis and endothelial cell biology
Giulia De Rossi et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Matrikines from basement membrane collagens: A new anti-cancer strategy
Jean Claude Monboisse et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism
M. Donet et al.
BRITISH JOURNAL OF CANCER (2014)
Matricryptins and matrikines: biologically active fragments of the extracellular matrix
Sylvie Ricard-Blum et al.
EXPERIMENTAL DERMATOLOGY (2014)
Regulation of intracellular signaling and function by caveolin
Heidi N. Fridolfsson et al.
FASEB JOURNAL (2014)
A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells
Estefania Ugarte-Berzal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Endorepellin Evokes Autophagy in Endothelial Cells
Chiara Poluzzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling
Anthony Ambesi et al.
JOURNAL OF CELL SCIENCE (2014)
Surface Engineered Dendrimers as Antiangiogenic Agent and Carrier for Anticancer Drug: Dual Attack on Cancer
K. Jain et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2014)
A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer
Jing Zhao et al.
MEDICAL ONCOLOGY (2014)
Low Molecular Weight Hyaluronan Induces Lymphangiogenesis through LYVE-1-Mediated Signaling Pathways
Man Wu et al.
PLOS ONE (2014)
Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys
Lifang Guo et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
Mark A. Lemmon et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Improving the therapeutic potential of endostatin by fusing it with the BAX BH3 death domain
R. M. Chura-Chambi et al.
CELL DEATH & DISEASE (2014)
Hyaluronan and RHAMM in Wound Repair and the Cancerization of Stromal Tissues
Cornelia Tolg et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Syndecans as modulators and potential pharmacological targets in cancer progression
Despoina Barbouri et al.
FRONTIERS IN ONCOLOGY (2014)
An experimental research into endostatin microbubble combined with focused ultrasound for anti-tumor angiogenesis in colon cancer
Xiufeng Zhang et al.
GASTROENTEROLOGY REPORT (2014)
Phase I trial of M2ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer
Yang Chen et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Generation of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragment
Zheng Qiu et al.
ANTI-CANCER DRUGS (2013)
A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle
Jessica Thevenard et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Endorepellin laminin-like globular 1/2 domains bind Ig35 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells
Chris D. Willis et al.
FEBS JOURNAL (2013)
Integrin signaling in control of tumor growth and progression
Jiangling Xiong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Interaction between the Elastin Peptide VGVAPG and Human Elastin Binding Protein
Charlotte Blanchevoye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Jonathan Welti et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Extra Cellular Matrix Derived Metabolite Regulates Angiogenesis by FasL Mediated Apoptosis
Raj K. Verma et al.
PLOS ONE (2013)
Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
Yun-Yan Wan et al.
RESPIRATORY RESEARCH (2013)
Laminin-111-derived peptides and cancer
Yamato Kikkawa et al.
CELL ADHESION & MIGRATION (2013)
Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy
Yi Zheng et al.
NANOSCALE RESEARCH LETTERS (2013)
The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells
Nan Song et al.
ANGIOGENESIS (2012)
Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin
Haining Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Inhibition of T-type Ca2+channels by endostatin attenuates human glioblastoma cell proliferation and migration
Yuan Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA
Simon Toupance et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Integrin Control of Tumor Invasion
Dara S. Missan et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Syndecan and integrin interactomes: large complexes in small spaces
James A. Roper et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2012)
Cell Surface Proteoglycans Syndecan-1 and-4 Bind Overlapping but Distinct Sites in Laminin α3 LG45 Protein Domain
Sonia Carulli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells
Estefania Ugarte-Berzal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Endorepellin Affects Angiogenesis by Antagonizing Diverse Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-evoked Signaling Pathways TRANSCRIPTIONAL REPRESSION OF HYPOXIA-INDUCIBLE FACTOR 1α AND VEGFA AND CONCURRENT INHIBITION OF NUCLEAR FACTOR OF ACTIVATED T CELL 1 (NFAT1) ACTIVATION
Atul Goyal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering
Cuixia Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Chemokine receptor CXCR2: Physiology regulator and neuroinflammation controller?
Mike Veenstra et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
An Inside View: VEGF Receptor Trafficking and Signaling
Michael Simons
PHYSIOLOGY (2012)
Tetrastatin, the NC1 Domain of the α4(IV) Collagen Chain: A Novel Potent Anti-Tumor Matrikine
Sylvie Brassart-Pasco et al.
PLOS ONE (2012)
Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma
Mari Aikio et al.
PLOS ONE (2012)
Characterization of the Interaction Between Endostatin Short Peptide and VEGF Receptor 3
Kyu-Yeon Han et al.
PROTEIN AND PEPTIDE LETTERS (2012)
A Peptide Derived from Endostatin Ameliorates Organ Fibrosis
Yukie Yamaguchi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
Rong Biaoxue et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Penetration of Endothelial Cell Coated Multicellular Tumor Spheroids by Iron Oxide Nanoparticles
Don N. Ho et al.
THERANOSTICS (2012)
Low-dose endostatin normalizes the structure and function of tumor vasculature and improves the delivery and anti-tumor efficacy of cytotoxic drugs in a lung cancer xenograft murine model
Tao Ning et al.
THORACIC CANCER (2012)
Target-Derived Matricryptins Organize Cerebellar Synapse Formation through α3β1 Integrins
Jianmin Su et al.
CELL REPORTS (2012)
CXCR2: from bench to bedside
Anika Stadtmann et al.
FRONTIERS IN IMMUNOLOGY (2012)
The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling
Shinya Hayashi et al.
BONE (2011)
Anti-Angiogenic Peptides for Cancer Therapeutics
Elena V. Rosca et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion
Lilly Y. W. Bourguignon et al.
CYTOSKELETON (2011)
TWO ENDOGENOUS ANTIANGIOGENIC INHIBITORS, ENDOSTATIN AND ANGIOSTATIN, DEMONSTRATE BIPHASIC CURVES IN THEIR ANTITUMOR PROFILES
Kashi Javaherian et al.
DOSE-RESPONSE (2011)
Matricryptins derived from collagens and proteoglycans
Sylvie Ricard-Blum et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Inhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteins
Yawu Jing et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the α2β1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) A DUAL RECEPTOR ANTAGONISM
Atul Goyal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents
Boyeon Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeted Delivery of an Antibody-Mutant Human Endostatin Fusion Protein Results in Enhanced Antitumor Efficacy
Seung-Uon Shin et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix
Chandra Shekhar Boosani et al.
PHARMACEUTICALS (2011)
Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling
Felix S. Gruenewald et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Tina Manon-Jensen et al.
FEBS JOURNAL (2010)
Degradation of tropoelastin by matrix metalloproteinases - cleavage site specificities and release of matrikines
Andrea Heinz et al.
FEBS JOURNAL (2010)
Characterization of a monoPEG20000-Endostar
Yue Tong et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2010)
Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
Sanyuan Hu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2010)
Type IIB Procollagen NH2-propeptide Induces Death of Tumor Cells via Interaction with Integrins αVβ3 and αVβ5
Zhepeng Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo
Yan He et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Endogenous Matrix-Derived Inhibitors of Angiogenesis
Malin Sund et al.
PHARMACEUTICALS (2010)
N-terminal modification increases the stability of the recombinant human endostatin in vitro
Li-Ping Jiang et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2009)
Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity
Alexander Nystroem et al.
BLOOD (2009)
Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice
Qing-Lian Wen et al.
CANCER SCIENCE (2009)
Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
Bryan P. Toole
CLINICAL CANCER RESEARCH (2009)
The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice
Ravesanker Ezhilarasan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin
S. Matou-Nasri et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
The First Draft of the Endostatin Interaction Network
Clement Faye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular Interplay between Endostatin, Integrins, and Heparan Sulfate
Clement Faye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and β-catenin levels
Tri Minh Bui Nguyen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Anastellin, the Angiostatic Fibronectin Peptide, Is a Selective Inhibitor of Lysophospholipid Signaling
Anthony Ambesi et al.
MOLECULAR CANCER RESEARCH (2009)
The role of osteopontin in inflammatory processes
Susan Amanda Lund et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
VEGF receptor protein-tyrosine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Autophagic Cell Death of Human Hepatoma Cells Induced by Endostar, a Recombinant Human Endostatin
Gang Wu et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Targeting a tumor-specific laminin domain critical for human carcinogenesis
Mark Tran et al.
CANCER RESEARCH (2008)
Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors
Namali T. Fernando et al.
CLINICAL CANCER RESEARCH (2008)
Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy
Tong-Young Lee et al.
CLINICAL CANCER RESEARCH (2008)
Endostatin and anastellin inhibit distinct aspects of the angiogenic process
David M. Neskey et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor
Peter Pocza et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing
F. Gao et al.
CLINICAL AND INVESTIGATIVE MEDICINE (2008)
Synergistic control of cell adhesion by integrins and syndecans
Mark R. Morgan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin
Hubing Shi et al.
BLOOD (2007)
An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma
V. Takafuji et al.
ONCOGENE (2007)
A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors
Xubin Lin et al.
CANCER BIOLOGY & THERAPY (2007)
The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit
Laurent Duca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Induction of macrophage migration through lactose-insensitive receptor by elastin-derived nonapeptides and their analog
Iori Maeda et al.
JOURNAL OF PEPTIDE SCIENCE (2007)
The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer
Chengyin Min et al.
CANCER RESEARCH (2007)
The PTEN/Akt pathway dictates the direct αvβ3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo
Tomohiro Kawaguchi et al.
CANCER RESEARCH (2006)
Construction, expression, and characterization of a new targeted bifunctional fusion protein: Tumstatin45-132-TNF
Yi-Qin Luo et al.
IUBMB LIFE (2006)
p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase
Jose G. Teodoro et al.
SCIENCE (2006)
Integrin α3β1, a Novel Receptor for α3(IV) noncollagenous domain and a trans-dominant inhibitor for integrin αvβ3
Corina M. Borza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin
Yongjun Nie et al.
BIOCONJUGATE CHEMISTRY (2006)
Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve
I Celik et al.
CANCER RESEARCH (2005)
被撤回的出版物: Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin (Retracted article. See vol. 130, pg. 552, 2020)
A Sudhakar et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Distinct structural requirements for binding of the integrins αvβ6, αvβ3, αvβ5, α5β1 and α9β1 to osteopontin
Y Yokosaki et al.
MATRIX BIOLOGY (2005)
Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with αvβ3 and αvβ3 integrins
C Magnon et al.
CANCER RESEARCH (2005)
Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110γ/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts
L Duca et al.
MOLECULAR PHARMACOLOGY (2005)
Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP
A Robinet et al.
JOURNAL OF CELL SCIENCE (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Hyaluronan fragments stimulate endothelial recognition of injury through TLR4
KR Taylor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
αvβ3 and αvβ5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the α3 chain of type IV collagen -: Implication for the mechanism of endothelial cell adhesion
V Pedchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling -: Role of divalent cations
S Ricard-Blum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity
SA Wickström et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human tumstatin land human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins
A Sudhakar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution
S Schenk et al.
JOURNAL OF CELL BIOLOGY (2003)
Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1
YM Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1
J Hanai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumstatin, an endothelial cell-specific inhibitor of protein synthesis
Y Maeshima et al.
SCIENCE (2002)
Cell adhesion and signaling on the fibronectin 1st type III repeat; requisite roles for cell surface proteoglycans and integrins
KO Mercurius et al.
BMC CELL BIOLOGY (2001)
Structural elements of the osteopontin SVVYGLR motif important for the interaction with α4 integrins
PM Green et al.
FEBS LETTERS (2001)
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor
CS Swindle et al.
JOURNAL OF CELL BIOLOGY (2001)
Identification of dual α4β1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin
KJ Bayless et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cell surface glypicans are low-affinity endostatin receptors
SA Karumanchi et al.
MOLECULAR CELL (2001)
The α3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the β3 subunit of integrin αvβ3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation
S Pasco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties
Y Maeshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
New functions for non-collagenous domains of human collagen type IV -: Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo
E Petitclerc et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules
GE Davis et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
